In summary, we have strong converging evidence of reduced alcohol use in individuals taking Semaglutide or Tirzepatide
A Category 1 designation means there is sufficient evidence to support safe compounding not that the compound is FDA-approved as a drug
This precision supports stacking compatibility in academic lab settings, where cross-reactivity with other metabolic or neuroendocrine targets must be carefully controlled
Acute kidney injury (AKI) - Severe vomiting or diarrhoea can cause dehydration and secondary kidney injury
There is no universal safest dosage
Common Reasons People Use BPC-157 Joint, tendon, or ligament pain and injuries Muscle strains and tears Post-surgical recovery Chronic inflammation Exercise-related overuse injuries Digestive and gut health issues General tissue healing support BPC-157 often produces noticeable improvements faster than sermorelin, particularly for specific pain or injury complaints, with some patients reporting changes within 1-2 weeks